We’re not even a month into the new Trump administration, and it feels like he’s moving at a breakneck pace to undo everything from the previous one.
Perhaps the most noteworthy order to date was when the president gave the green light to the Dakota Access and Keystone XL Pipeline projects.
It really was only a matter of time, especially considering the state of our country’s failing infrastructure.
However, this is just the beginning of his master plan.
Over the next few years, he’s going to pour up to $1 trillion into our roads, bridges, and yes… more pipelines!
The Curse of B&O
You and I both understand how bad the situation has become.
However, as I hinted on Wednesday, there’s another sector about to undergo a massive revival: energy infrastructure.
I’m referring, of course, to the vast, 2.5 million-mile pipeline network set up to ensure that crude oil (vital to our country’s transportation sector) can get to market.
But to really boil things down further, look no further than the Bakken shale play in North Dakota.
Right now, more than half of the oil extracted from Bakken wells has to be transported out of the state by rail, and that’s causing big problems.
As you can see below, North Dakota actually reached its pipeline capacity years ago!
Shipping crude by freight not only comes with its own delays and bottlenecks, but it also comes with a much higher price tag — as much as double the costs to move crude through pipelines.
That means fewer profits in your pocket.
Our analysts have traveled the world over, dedicated to finding the best and most profitable investments in the global energy markets. All you have to do to join our Energy and Capital investment community is sign up for the daily newsletter below.
The Steadiest Income You’ll Ever Receive Through Investing
Look, we knew long before Trump was sworn into office that he would be a huge supporter of our country’s oil and gas companies.
And considering the fact that the United States is consuming upwards of 19 million barrels of petroleum products every single day, you can understand just how much we truly rely on our pipeline system.
What you may not be aware of, however, is that 60% of U.S. fuel pipelines are more than 50 years old!
That’s about the life expectancy of our steel pipelines.
So you can see now why we don’t have another 10 or 20 years to sit on our thumbs and argue about whether or not it’s a good investment for America.
Moreover, Trump has made it clear that absolutely nothing is going to stand in the way of any company hoping to develop a new pipeline project. Not Congress. Not the EPA. And not protesters.
But it’s not enough to just rant and rave about this crisis. I want to show you exactly how Wall Street is going to make billions off of this infrastructure boom — before they do!
Look, I don’t want you to take my word for granted, which is why I’ve put all the details into my new investment presentation. This short video will lay down the real story about how small investors like us can take advantage of this opportunity right away.
Taking that first step, however, is up to you.
Until next time,
Keith Kohl
Check us out on YouTube!A true insider in the technology and energy markets, Keith’s research has helped everyday investors capitalize from the rapid adoption of new technology trends and energy transitions. Keith connects with hundreds of thousands of readers as the Managing Editor of Energy & Capital, as well as the investment director of Angel Publishing’s Energy Investor and Technology and Opportunity.
For nearly two decades, Keith has been providing in-depth coverage of the hottest investment trends before they go mainstream — from the shale oil and gas boom in the United States to the red-hot EV revolution currently underway. Keith and his readers have banked hundreds of winning trades on the 5G rollout and on key advancements in robotics and AI technology.
Keith’s keen trading acumen and investment research also extend all the way into the complex biotech sector, where he and his readers take advantage of the newest and most groundbreaking medical therapies being developed by nearly 1,000 biotech companies. His network includes hundreds of experts, from M.D.s and Ph.D.s to lab scientists grinding out the latest medical technology and treatments. You can join his vast investment community and target the most profitable biotech stocks in Keith’s Topline Trader advisory newsletter.
